Exparel 266 MG/20 ML vial 20ML

Ended Awarded

Contract number
SPE2DX24FUKAT
Awardee
Awarding agency
Obligated
$7,462

Award facts

Contract value 100% obligated
$7,461.66 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The fixed-price contract has a ceiling value of $7,461.66 and a completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (SPE2DB) that DMS Pharmaceutical Group holds with the DLA, valued at up to $4,999,999 through the end of 2025, for the supply of a broad range of pharmaceutical items to military health facilities worldwide. The contract has no set-aside designation.

Quick answers

Who was awarded contract SPE2DX24FUKAT?

SPE2DX24FUKAT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on March 18, 2024.

How much is contract SPE2DX24FUKAT worth?

The government has obligated $7,462 on SPE2DX24FUKAT.

Is contract SPE2DX24FUKAT an order under another contract?

Yes. SPE2DX24FUKAT is a delivery order under SPE2DX15D9223, an indefinite delivery contract.

Was contract SPE2DX24FUKAT competed?

The extent of competition for SPE2DX24FUKAT was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login